113 related articles for article (PubMed ID: 10850547)
1. Novel polymerase chain reaction approach for full-coding p53 mutation detection in microdissected archival tumors.
Thompson-Hehir J; Davies MP; Green JA; Halliwell N; Joyce KA; Salisbury J; Sibson DR; Vergote I; Walker C
Diagn Mol Pathol; 2000 Jun; 9(2):110-9. PubMed ID: 10850547
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of archival non-buffered formalin-fixed and paraffin-embedded tissues for PCR amplification: an analysis of resected gastric carcinoma.
Inoue T; Nabeshima K; Kataoka H; Koono M
Pathol Int; 1996 Dec; 46(12):997-1004. PubMed ID: 9110353
[TBL] [Abstract][Full Text] [Related]
3. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
[TBL] [Abstract][Full Text] [Related]
4. A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors.
Soong R; Iacopetta BJ
Mod Pathol; 1997 Mar; 10(3):252-8. PubMed ID: 9071734
[TBL] [Abstract][Full Text] [Related]
5. Identification of deletions and insertions in the p53 gene using multiplex PCR and high-resolution fragment analysis: application to breast and ovarian tumors.
Angelopoulou K; Diamandis EP
J Clin Lab Anal; 1998; 12(4):250-6. PubMed ID: 9671178
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive TP53-denaturing gradient gel electrophoresis mutation detection assay also applicable to archival paraffin-embedded tissue.
Hayes VM; Bleeker W; Verlind E; Timmer T; Karrenbeld A; Plukker JT; Marx MP; Hofstra RM; Buys CH
Diagn Mol Pathol; 1999 Mar; 8(1):2-10. PubMed ID: 10408787
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line.
Chow VT; Quek HH; Tock EP
Cancer Lett; 1993 Sep; 73(2-3):141-8. PubMed ID: 8221626
[TBL] [Abstract][Full Text] [Related]
8. p53 mutation is a common genetic event in ovarian carcinoma.
Milner BJ; Allan LA; Eccles DM; Kitchener HC; Leonard RC; Kelly KF; Parkin DE; Haites NE
Cancer Res; 1993 May; 53(9):2128-32. PubMed ID: 8481915
[TBL] [Abstract][Full Text] [Related]
9. p53 mutation in carcinomas arising in ovarian cystic teratomas.
Fujii T; Oguni S; Kikuchi M; Kanai N; Saito K
Pathol Int; 1995 Sep; 45(9):649-54. PubMed ID: 8548037
[TBL] [Abstract][Full Text] [Related]
10. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.
Navone NM; Troncoso P; Pisters LL; Goodrow TL; Palmer JL; Nichols WW; von Eschenbach AC; Conti CJ
J Natl Cancer Inst; 1993 Oct; 85(20):1657-69. PubMed ID: 7692074
[TBL] [Abstract][Full Text] [Related]
11. Discordance in p53 mutations when comparing ascites and solid tumors from patients with serous ovarian cancer.
Provencher DM; Lounis H; Fink D; Drouin P; Mes-Masson AM
Tumour Biol; 1997; 18(3):167-74. PubMed ID: 9143413
[TBL] [Abstract][Full Text] [Related]
12. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
[TBL] [Abstract][Full Text] [Related]
13. Oligonucleotide probe array for p53 gene alteration analysis in DNA from formalin-fixed paraffin-embedded breast cancer tissues.
Lumachi F; Marino F; Varotto S; Basso U
Ann N Y Acad Sci; 2009 Sep; 1175():89-92. PubMed ID: 19796081
[TBL] [Abstract][Full Text] [Related]
14. Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections.
Chen T; Dhingra K; Sahin A; Sneige N; Hortobagyi G; Aldaz CM
Breast Cancer Res Treat; 1996; 39(2):177-85. PubMed ID: 8872326
[TBL] [Abstract][Full Text] [Related]
15. p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis.
Ito S; Ohga T; Saeki H; Nakamura T; Watanabe M; Tanaka S; Kakeji Y; Maehara Y
Int J Cancer; 2005 Jan; 113(1):22-8. PubMed ID: 15386362
[TBL] [Abstract][Full Text] [Related]
16. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma.
Sameshima Y; Tsunematsu Y; Watanabe S; Tsukamoto T; Kawa-ha K; Hirata Y; Mizoguchi H; Sugimura T; Terada M; Yokota J
J Natl Cancer Inst; 1992 May; 84(9):703-7. PubMed ID: 1569604
[TBL] [Abstract][Full Text] [Related]
17. p53 gene mutations and protein accumulation in human ovarian cancer.
Kupryjańczyk J; Thor AD; Beauchamp R; Merritt V; Edgerton SM; Bell DA; Yandell DW
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4961-5. PubMed ID: 8506342
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of p53 in prostate carcinoma is associated with improved overall survival but not predictive of response to radiotherapy.
Incognito LS; Cazares LH; Schellhammer PF; Kuban DA; Van Dyk EO; Moriarty RP; Wright GL; Somers KD
Int J Oncol; 2000 Oct; 17(4):761-9. PubMed ID: 10995889
[TBL] [Abstract][Full Text] [Related]
19. p53 mutation is infrequent in clear cell carcinoma of the ovary.
Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
[TBL] [Abstract][Full Text] [Related]
20. p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma.
Sood AK; Coffin J; Jabbari S; Buller RE; Hendrix MJ; Klingelhutz A
Cancer Biol Ther; 2002; 1(5):511-7. PubMed ID: 12496479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
